Megma Healthcare Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 08-07-2024
- Paid Up Capital ₹ 2.60 M
as on 08-07-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.74 Cr
as on 08-07-2024
- Revenue -11.88%
(FY 2021)
- Profit -10.08%
(FY 2021)
- Ebitda -15.11%
(FY 2021)
- Net Worth 19.21%
(FY 2021)
- Total Assets -9.61%
(FY 2021)
About Megma Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 2.60 M.
The company currently has active open charges totaling ₹2.74 Cr.
Jitender Singh and Shivam Sangwan serve as directors at the Company.
- CIN/LLPIN
U51397HR2013PTC118855
- Company No.
034835
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Megma Healthcare Private Limited offer?
Megma Healthcare Private Limited offers a wide range of products and services, including Anti Asthma Drug, Acebrophylline Capsules, Diabetes Medicine, Sitagliptin Tablet, Antihistamines, Phenylephrine Hcl Tablet, Dietary Supplements, Omega 3 Capsule, Amoxicillin drugs, Amoxicillin Potassium Clavulanate Tablet.
Who are the key members and board of directors at Megma Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitender Singh  | Director | 22-Nov-2013 | Current |
| Shivam Sangwan | Additional Director | 20-Sep-2021 | Current |
Financial Performance of Megma Healthcare.
Megma Healthcare Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.88% decrease. The company also saw a substantial fall in profitability, with a 10.08% decrease in profit. The company's net worth Soared by an impressive increase of 19.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Megma Healthcare?
In 2021, Megma Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 May 2023 | ₹1.14 M | Open |
Hdfc Bank Limited Creation Date: 12 Sep 2022 | ₹1.69 M | Open |
Hdfc Bank Limited Creation Date: 04 Sep 2021 | ₹0.77 M | Open |
How Many Employees Work at Megma Healthcare?
Unlock and access historical data on people associated with Megma Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Megma Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Megma Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
